Tag: Ottawa

Poster-Psychosocial Factors

Cognitive Fatigability and Cardiorespiratory Fitness in Persons with Advanced Multiple Sclerosis

Background: Fatigue, both physical and cognitive, is one of the most prevalent and disabling symptoms experienced by persons with multiple...

Read More

Poster-Psychosocial Factors

A Continuum of Languishing to Flourishing: A Qualitative Study of Psychological Resilience in Multiple Sclerosis Family Caregivers

Background: Informal unpaid family caregivers (e.g., spouses, parents, siblings) are the primary providers of support to people living with...

Read More

Poster-Neurophysiology; Neuropsychology and Neuropsychiatry

Validation of Paced Auditory Serial Addition Test (PASAT) Regression Normative Data for Performance and Cognitive Fatigability in Multiple Sclerosis

Background: Cognitive fatigability (CF) can be defined as an objective decline in performance that occurs over time during sustained...

Read More

Poster-Family and Caregivers

Profiles of Resilience Among MS Care Partners

Background: Psychological resilience may play an important role in protecting multiple sclerosis (MS) care-partners from the negative...

Read More

Poster-Disease-modifying Therapy

Post-Approval Safety of Subcutaneous Interferon ?-1a in the Treatment of Multiple Sclerosis, with Particular Reference to Respiratory Viral Infections

Background: Subcutaneous interferon ?-1a (sc IFN ?-1a) is a well-established disease-modifying therapy for relapsing multiple sclerosis...

Read More

Poster-Disease-modifying Therapy

Recently Diagnosed Treatment-Naive RRMS: 1-Year Safety Data from the Ocrelizumab Phase IIIb ENSEMBLE Study

Background: ENSEMBLE (NCT03085810) is a multicenter, open-label, single-arm Phase IIIb study evaluating the effectiveness and safety of...

Read More

Platform-Rehabilitation

Stakeholder Recommendations for a Dyadic Physical Activity Intervention for People with Moderate-to-Severe Multiple Sclerosis and Their Care-Partners: A Modified e-Delphi Study.

Background: People with moderate-to-severe multiple sclerosis (MS) and their family caregivers do not engage in sufficient physical...

Read More

Platform-Disease Modifying Therapies

Recently Diagnosed Early-Stage RRMS: Neda, ARR, Disability Progression, Serum Neurofilament and Safety: 1-Year Interim Data from the Ocrelizumab Phase IIIb ENSEMBLE Study

Background: Early treatment of multiple sclerosis (MS) and rapid onset of therapeutic effect provide long-term benefits on disease...

Read More